NanoVibronix (NAOV) reported Tuesday direct offering of 291,204 shares of its common stock or equivalents at a price of $7.01 per share, to raise around $2 million.
The medical technology company plans to use net proceeds from the offering for repayment of certain outstanding debt and redemption of certain outstanding preferred stock, it added.
The offering is expected to close on Wednesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments